Astrivax
- Biotech or pharma, therapeutic R&D
Immune therapy company with a novel therapeutic vaccine platform technology addressing therapeutic indications. Clinical POC data has been generated for our prototypic vaccines and we now have laser focus on therapeutic indications for Human Papilloma Virus and Chronic Hepatitis B, both with significant market potential. Our business model is develop our platform by our focus on internal programs while actively seeking partners to expand the use of our platform into other therapeutic indications and areas.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}